Serum Calcification Propensity T50 Is Associated with Soluble Thrombomodulin in Patients on Hemodialysis.

MLA

Tadokoro, Takeshi, et al. “Serum Calcification Propensity T50 Is Associated with Soluble Thrombomodulin in Patients on Hemodialysis.” Journal of Clinical Medicine, vol. 13, no. 12, June 2024. EBSCOhost, https://doi.org/10.3390/jcm13123491.

APA

Tadokoro, T., Kato, A., Ohmori, H., Matsumoto, T., Kuro-O, M., Kobayashi, T., & Ohdan, H. (2024). Serum Calcification Propensity T50 Is Associated with Soluble Thrombomodulin in Patients on Hemodialysis. Journal of Clinical Medicine, 13(12). https://doi.org/10.3390/jcm13123491

Chicago

Tadokoro, Takeshi, Akihiko Kato, Hiromitsu Ohmori, Tomio Matsumoto, Makoto Kuro-O, Tsuyoshi Kobayashi, and Hideki Ohdan. 2024. “Serum Calcification Propensity T50 Is Associated with Soluble Thrombomodulin in Patients on Hemodialysis.” Journal of Clinical Medicine 13 (12). doi:10.3390/jcm13123491.